CLC Bio Customized Software Supports Abcam's Monoclonal Development Capability
News Nov 07, 2007
CLC bio and Abcam have announced that CLC bio has met the first important milestone of the two companies’ collaboration: the development of a customized epitope prediction software solution to augment Abcam’s high through-put monoclonal antibody development programme.
Through automation of labor intensive manual workflows and by applying expert scientific knowledge, CLC bio’s customized bioinformatics solution ensures a reduction in the time-to-market whilst ensuring that the antibodies are of the highest quality.
Dr Catherine Onley, Head of Product Development & Manufacture at Abcam, states: 'We searched the market to find the best bioinformatics solution provider for this highly specialized project and I am more than satisfied with CLC bio’s performance. Their skilled IT developers and experienced bioinformatics scientists and project manager have developed an epitope prediction solution that exceeds our expectations. Abcam’s in-house R&D programme will benefit significantly from this. I look forward to the next phase of our collaboration, where we will fully integrate the epitope prediction solution with our LIMS system.'
Dr Jannick D. Bendtsen, project manager and Senior Scientific Officer at CLC bio, said: 'We are very proud to help Abcam improve their R&D workflows and performance through this software consulting assignment. From a personal perspective, I’m thrilled to work on this Abcam project as it has been scientifically challenging. I look forward to seeing Abcam improve their competitive edge using this new bioinformatics solution.'
Parts of the epitope prediction functionalities will be included in future versions of CLC Protein Workbench and CLC Combined Workbench, which will facilitate epitope prediction in basic research. The Abcam-related work will be kept confidential between the two parties.
The Abcam solution is designed as a plug-in that is then fully integrated with the CLC Combined Workbench, CLC bio's desktop-based DNA, RNA, and protein sequence analysis and data management software.
Largest Genetic Study of Osteoarthritis Advances ResearchNews
Osteoarthritis is a complex disease, and the genetic basis of the disease has proved difficult to pin down. A new study from the Sanger Institute provides much-needed hope.READ MORE
The DNA Shuffle: Barcoding Trick is Boost to RNA-SeqNews
SPLiT-seq is a new technology that can separate thousands of cells using innovative barcoding technology.READ MORE
Comments | 0 ADD COMMENT
World Congress on Advanced Pharmacy and Clinical Research
Jul 16 - Jul 17, 2018
11th International Conference and Exhibition on Metabolomics & Systems Biology
May 17 - May 19, 2018
6th Annual Congress on Biology and Medicine of Molecules
Sep 17 - Sep 18, 2018
World Congress on Pathology and Laboratory Medicine
Sep 10 - Sep 11, 2018
International Conference on Molecular Biology and Stem Cells
Aug 13 - Aug 15, 2018